Oncolytics Biotech, Inc. (ONCY)
0.4733
-0.08
(-15.03%)
USD |
NASDAQ |
Oct 12, 16:00
0.4795
+0.01
(+1.31%)
Pre-Market: 08:47
Oncolytics Biotech Free Cash Flow : -26.53M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.53M |
| March 31, 2026 | -22.73M |
| December 31, 2025 | -19.96M |
| September 30, 2025 | -18.89M |
| June 30, 2025 | -17.84M |
| March 31, 2025 | -18.63M |
| December 31, 2024 | -19.65M |
| September 30, 2024 | -18.95M |
| June 30, 2024 | -19.59M |
| March 31, 2024 | -20.84M |
| December 31, 2023 | -21.09M |
| September 30, 2023 | -20.96M |
| June 30, 2023 | -19.73M |
| March 31, 2023 | -18.85M |
| December 31, 2022 | -18.02M |
| September 30, 2022 | -18.73M |
| June 30, 2022 | -18.60M |
| March 31, 2022 | -18.72M |
| December 31, 2021 | -18.15M |
| September 30, 2021 | -17.46M |
| June 30, 2021 | -18.94M |
| March 31, 2021 | -17.92M |
| December 31, 2020 | -16.47M |
| September 30, 2020 | -17.57M |
| June 30, 2020 | -16.39M |
| Date | Value |
|---|---|
| March 31, 2020 | -15.42M |
| December 31, 2019 | -15.02M |
| September 30, 2019 | -12.84M |
| June 30, 2019 | -12.13M |
| March 31, 2019 | -8.153M |
| December 31, 2018 | -9.281M |
| September 30, 2018 | -8.507M |
| June 30, 2018 | -8.333M |
| March 31, 2018 | -12.20M |
| December 31, 2017 | -11.51M |
| September 30, 2017 | -11.83M |
| June 30, 2017 | -11.61M |
| March 31, 2017 | -10.21M |
| December 31, 2016 | -9.425M |
| September 30, 2016 | -9.835M |
| June 30, 2016 | -9.712M |
| March 31, 2016 | -11.85M |
| December 31, 2015 | -11.87M |
| September 30, 2015 | -11.54M |
| June 30, 2015 | -13.50M |
| March 31, 2015 | -14.63M |
| December 31, 2014 | -18.00M |
| September 30, 2014 | -19.27M |
| June 30, 2014 | -21.48M |
| March 31, 2014 | -21.30M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Sangamo Therapeutics, Inc. | -90.46M |
| Sarepta Therapeutics, Inc. | 58.34M |
| Anixa Biosciences, Inc. | -7.376M |
| Mera Pharmaceuticals, Inc. | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.066M |
| Cash from Financing (Quarterly) | 6.704M |
| Free Cash Flow Per Share (Quarterly) | -0.0674 |
| Free Cash Flow to Equity (Quarterly) | -8.006M |
| Free Cash Flow to Firm (Quarterly) | -8.066M |
| Free Cash Flow Yield | -50.80% |